Viewing Study NCT04816669


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2026-01-26 @ 8:18 AM
Study NCT ID: NCT04816669
Status: COMPLETED
Last Update Posted: 2022-12-23
First Post: 2021-03-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults
Sponsor: BioNTech SE
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None SARS-CoV-2 Infection View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None Coronavirus View
None Vaccine View
None SARS-CoV-2 View
None RNA Vaccine View